Among the 33 types of cancer, the overall survival or disease-free survival rates for patients with adrenocortical carcinoma (ACC), brain lower-grade glioma (LGG), liver hepatocellular carcinoma (LIHC), mesothelioma (MESO), or pancreatic adenocarcinoma (PAAD) were negatively correlated with higher expression levels of the NRF3 gene, including two or more genes among SLC36A1, SLC38A9, RagC, each RAB5 isoforms, and SLC7A1 genes (Figure 7D). This evidence concerns the gene SLC7A1 and adrenal cortex carcinoma.